Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year
"Winning a fourth Top Workplaces USA Award is a testament to our exceptional Castle team and people-first culture," said Derek Maetzold, president and chief executive officer of Castle Biosciences. "We are committed to fostering an environment where employees feel valued, supported and empowered to drive innovation, and this recognition reflects their passion and dedication to making a meaningful impact on patient care."
More than 42,000 organizations were invited to participate in the Top Workplaces USA survey. Winners of the Top Workplaces USA list were chosen solely on employee feedback gathered through a third-party employee engagement survey administered by Energage. Results were calculated by comparing the survey's research-based statements, including 15 culture drivers that are indicative of high performance against industry benchmarks. Castle's survey participation rate of 95% and employee engagement score of 85% were both above the benchmark averages of 56% and 74%, respectively, for other similar healthcare companies participating in the Top Workplaces USA program.
'Earning a Top Workplaces award is a badge of honor for companies, especially because it comes authentically from their employees,' said Eric Rubino, Energage CEO. 'That's something to be proud of. In today's market, leaders must ensure they're allowing employees to have a voice and be heard. That's paramount. Top Workplaces do this, and it pays dividends.'
The comprehensive list of 2025 Top Workplaces USA can be found on USAToday.com and TopWorkplaces.com.
About Castle BiosciencesCastle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
Castle's current portfolio consists of tests for skin cancers, Barrett's esophagus, mental health conditions and uveal melanoma. Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
About Energage
Making the world a better place to work together.™Energage is a purpose-driven company that helps organizations turn employee feedback into useful business intelligence and credible employer recognition through Top Workplaces. Built on 19 years of culture research and the results from 27 million employees surveyed across more than 70,000 organizations, Energage delivers the most accurate competitive benchmark available. With access to a unique combination of patented analytic tools and expert guidance, Energage customers lead the competition with an engaged workforce and an opportunity to gain recognition for their people-first approach to culture. For more information or to nominate your organization, visit energage.com or topworkplaces.com.
Investor Contact:Camilla Zuckeroczuckero@castlebiosciences.com
Media Contact:Allison Marshallamarshall@castlebiosciences.com
Source: Castle Biosciences Inc.Sign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
This Artificial Intelligence (AI) Stock Is Growing Fast and Still Trades at Just 10 Times Earnings
Key Points Micron Technology is now expecting stronger growth in the current quarter, as greater demand is allowing it to increase memory pricing. The company supplies its AI-focused memory chips to all the leading players in this space. Micron's ability to deliver phenomenal growth makes it a no-brainer buy right now, particularly considering its cheap valuation. 10 stocks we like better than Micron Technology › Micron Technology (NASDAQ: MU) is playing a central role in the adoption of artificial intelligence (AI) technology: Its memory chips are being used by top chip designers such as Nvidia and Advanced Micro Devices in their data center graphics cards. Micron's high-bandwidth memory (HBM) suits the technical needs of AI accelerator graphics processing units (GPUs) because they are capable of moving huge amounts of data with low lag, and are more energy efficient than conventional memory chips. And given the high demand for AI chips, demand for Micron's HBM chips has also been robust, which explains why its growth has been remarkable in recent quarters. Importantly, it appears Micron's terrific growth will persist thanks to its lucrative opportunity in the HBM space -- and its latest guidance update provides further evidence to that effect. Micron Technology's AI-fueled growth is just getting started On Monday, Micron increased its guidance for its fiscal 2025 fourth quarter. For the period, which will end Aug. 28, it now expects revenues of $11.1 billion to $11.3 billion, up from a range of $10.4 billion to $11 billion previously. At the midpoint, that's a boost of $500 million. Additionally, management bumped up its non-GAAP earnings guidance from $2.50 per share to $2.85 per share. Those figures would equate to a year-over-year increase of 44% in revenue and a 141% jump in adjusted earnings per share. Micron management says that "improved pricing, particularly in DRAM, and strong execution" are the reasons behind its improved guidance. Booming demand for HBM is a key factor that's allowing memory makers to increase prices. According to one estimate, the HBM market's revenue could double in 2024 to $34 billion, driven by a combination of higher shipments and increased pricing. Specifically, production capacity constraints are expected to push up the price of HBM by 15% to 20% in the calendar third quarter, which would be sharper than the 5% to 10% growth seen in the previous quarter. At the same time, the next iterations of AI graphics cards designed by Nvidia and AMD will be equipped with bigger HBM chips. Nvidia, for instance, is packing 288 gigabytes (GB) of HBM into its Blackwell Ultra B300 GPU, up from the 192GB configuration of the B200. Similarly, AMD is bumping up the HBM capacity of its MI355X and MI350X accelerators to 288GB; the previous generation MI325X had 256GB. What's more, AMD is planning to increase the HBM capacity of its next-generation MI400X GPUs to a whopping 432GB. Given all that, demand for HBM is likely to remain solid. Micron's peer SK Hynix is forecasting annualized increases of 30% in the HBM market through 2030. AI, therefore, can be expected to remain a solid long-term growth driver for Micron, especially considering the company's improving share of this market. The memory specialist says it's supplying HBM chips "in high volume" to four major customers, which indicates that custom AI chipmakers such as Broadcom and Marvell Technology are also among its big clients. Not surprisingly, Micron's HBM market share is expected to jump to 24% by the end of 2025 as compared to around 20% earlier this year. That potential improvement in Micron's market share, along with the outstanding growth of the HBM market, explains why analysts have increased their revenue growth expectations from the company. Even better, Micron's healthy top-line growth will drive a big jump in the company's bottom line since demand for HBM is outpacing supply. The favorable supply-and-demand dynamic should lift memory prices and supercharge Micron's earnings, which is why buying the stock right now is a no-brainer. Micron stock is too cheap to ignore Micron reported $1.30 per share in earnings in its fiscal 2024. The following chart makes it clear that its earnings are on track to grow significantly in the current fiscal year and beyond. The best part for investors is that Micron stock is trading at just 10 times forward earnings, which is dirt cheap considering the earnings growth that it's projected to deliver. Its forward earnings multiple is significantly lower than the tech-laden Nasdaq-100 index's multiple of 30. Ideally, the market will reward the AI-fueled growth that this chipmaker is set to deliver with a higher earnings multiple. For instance, an earnings multiple of even 20 after a year could send its stock price to $244 (based on its fiscal 2026 earnings estimate of $12.22 per share). That would be nearly double its current stock price. So, investors should consider buying this AI stock hand over fist as it has the potential to fly higher, even after recording a 52% gain so far in 2025. Should you invest $1,000 in Micron Technology right now? Before you buy stock in Micron Technology, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Micron Technology wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $663,630!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,695!* Now, it's worth noting Stock Advisor's total average return is 1,071% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Harsh Chauhan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices and Nvidia. The Motley Fool recommends Broadcom and Marvell Technology. The Motley Fool has a disclosure policy. This Artificial Intelligence (AI) Stock Is Growing Fast and Still Trades at Just 10 Times Earnings was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
Crypto analyst says Dogecoin could repeat 2021 cycle to hit around $7
Crypto analyst says Dogecoin could repeat 2021 cycle to hit around $7 originally appeared on TheStreet. Popular crypto expert, known as @CryptoKaleo on X, is eyeing a Dogecoin breakout soon enough. The pseudonymous expert shared a price analysis chart on X on Aug. 13, which showed similarities between the 2021 and current cycles. @CryptoKaleo highlighted that in January 2021, Dogecoin dipped in value following months of accumulation within a descending range. But the move was followed by a sharp breakout, which saw the meme coin surging by more than 8,000% to reach an all-time high (ATH) of $0.7376 on May 8, 2021. The analyst argued that DOGE is ready to make a similar move to that of January 2021, which he hopes will trigger the next epic breakout. Well, the meme coin's price trajectory since July 2021 has been nothing but a series of accumulations within descending ranges followed by modest breakouts. As per @CryptoKaleo, it's time for an epic breakout on the chart similar to what we witnessed in popular analyst is eyeing a price of $6.9420 for Dogecoin. They also expect crypto treasury firms to buy DOGE worth billions of dollars. We have recently seen Bit Origin (Nasdaq: BTOG) adopting a DOGE treasury strategy. The recent whale activity also requires our attention. Another popular analyst, known as @ali_charts on X, highlighted how DOGE whale activity was recently at a one-month high. "Expecting the god candle to initiate from there," @CryptoKaleo added. At press time, Dogecoin was trading at $0.2244. For it to hit the analyst's target of $6.9420, it needs to surge by more than 3,000%. Disclaimer: The content above is intended for informational purposes only and should not be taken as financial advice. Do your own research before investing. Crypto analyst says Dogecoin could repeat 2021 cycle to hit around $7 first appeared on TheStreet on Aug 14, 2025 This story was originally reported by TheStreet on Aug 14, 2025, where it first appeared. Sign in to access your portfolio
Associated Press
27 minutes ago
- Associated Press
MGE Energy Increases Dividend for 50th Consecutive Year
MADISON, Wis.--(BUSINESS WIRE)--Aug 15, 2025-- The board of directors of MGE Energy, Inc. (Nasdaq: MGEE), today increased the regular quarterly dividend rate 5.6% to $0.4750 per share on the outstanding shares of the company's common stock. The dividend is payable Sept. 15, 2025, to shareholders of record Sept. 1, 2025. This raises the annualized dividend rate by 10 cents from $1.80 per share to $1.90 per share. 'Today's action by our board marks a milestone that only a select number of companies have achieved of increasing the dividend for 50 consecutive years, reinforcing our commitment to consistent and sustainable dividend growth and signaling the continued strength of MGE Energy's long-term business strategy for building your community energy company for the future,' said Chairman, President and CEO Jeff Keebler. 'MGE Energy continues to focus on our mission to provide safe, reliable, affordable and sustainable energy and on our disciplined financial management to provide ongoing value to our customers and shareholders.' MGE Energy has paid cash dividends for more than 110 years. About MGE Energy MGE Energy is a public utility holding company. Its principal subsidiary, Madison Gas and Electric (MGE), generates and distributes electricity to 167,000 customers in Dane County, Wis., and purchases and distributes natural gas to 178,000 customers in seven south-central and western Wisconsin counties. MGE's roots in the Madison area date back more than 150 years. View source version on CONTACT: Steve Schultz Corporate Communications Manager 608-252-7219 |[email protected] Frassetto Investor Relations 608-252-4723 |[email protected] KEYWORD: UNITED STATES NORTH AMERICA WISCONSIN INDUSTRY KEYWORD: ENERGY OTHER ENERGY UTILITIES OIL/GAS SOURCE: MGE Energy, Inc. Copyright Business Wire 2025. PUB: 08/15/2025 12:26 PM/DISC: 08/15/2025 12:26 PM
